Cure My Disease

Don't miss your cure!

 Log in / Sign up

New european effort matches kids with relapsed leukemia to smarter treatments

NCT ID NCT05270096

Recruiting now Knowledge-focused Sponsor: Princess Maxima Center for Pediatric Oncology Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study helps doctors choose the best available therapy for children and young adults with relapsed or hard-to-treat blood cancers. A team of experts reviews each patient's tumor markers and history to recommend a personalized treatment plan. The study does not give any new drugs but tracks whether doctors follow the advice and how patients do. It aims to improve decision-making and outcomes for these young patients across Europe.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for REFRACTORY HEMATOLOGIC MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hematopoietic and lymphoid system neoplasm leukemia refractory hematologic cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

REFRACTORY HEMATOLOGIC MALIGNANCY RELAPSED HEMATOLOGIC MALIGNANCY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Newcastle Hospital

    RECRUITING

    Newcastle, United Kingdom

    Contact Email: •••••@•••••

  • Princess Máxima Center for Pediatric Oncology

    RECRUITING

    Utrecht, Utrecht, 3584CS, Netherlands

    Contact Email: •••••@•••••

  • Queen Silvia

    RECRUITING

    Gothenburg, Sweden

    Contact Email: •••••@•••••

  • Righospitalet

    RECRUITING

    Copenhagen, Denmark

    Contact Email: •••••@•••••

  • Semmelweis

    RECRUITING

    Budapest, Hungary

    Contact Email: •••••@•••••

  • UH Gent

    RECRUITING

    Ghent, Belgium

    Contact Email: •••••@•••••

  • Vall d'Hebron

    RECRUITING

    Barcelona, Spain

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.